NCT02338479 2023-02-08
Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies
Center for International Blood and Marrow Transplant Research
Unknown
Clinical Trials
19 trialsNCT05660993 2022-12-21
Multicenter Study of Safety and Efficacy of PET-adapted Treatment With Nivolumab, Bendamustine, Gemcitabine, Vinorelbine (Nivo-BeGEV) in Patients With Relapsed/Refractory Hodgkin Lymphoma
National Research Center for Hematology, Russia
Phase 2 Unknown
NCT05191225 2022-03-31
Ultrafast Truxima Infusion in Non-Hodgkin's Lymphoma: Txagorapid Study
Bioaraba Health Research Institute
Phase 4 Unknown
NCT03505944 2021-10-13
VALERIA
Nordic Lymphoma Group
Phase 1/2 Unknown
NCT00433433 2021-02-03
H10
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Unknown
NCT03479918 2018-03-27
R-BL-M-04 Versus R-(DA)-EPOCH and Autologous Stem Cells Transplantation in Patients With High-Grade B-cell Lymphoma Double-hit (HGBL DH) and High-Grade B-cell Lymphoma Not Otherwise Specified (HGBL NOS)
National Research Center for Hematology, Russia
Phase 3 Unknown
NCT03462095 2018-03-13
De-escalated Treatment Approach for Adult Ph-negative Acute Lymphoblastic Leukemia (ALL)
National Research Center for Hematology, Russia
Phase NA Unknown
NCT01193933 2018-03-07
Multicenter Clinical Trial for Adult Ph-negative ALL. Non-intensive But Non-iterruptive Treatment
National Research Center for Hematology, Russia
Phase NA Unknown
NCT01185886 2017-07-28
Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia
European Organisation for Research and Treatment of Cancer - EORTC
Unknown
NCT03207789 2017-07-05
Tcell-Brazil
Grupo de Estudos Multicentricos em Onco-Hematologia
Unknown
NCT02842931 2016-07-25
R-Dose-adjusted (DA) - EPOCH-21 Versus R-modified Non-Hodgkin Lymphoma (NHL)-Berlin-Frankfurt-Munster (BFM)-90 Program (mNHL-BFM-90) and Autologous Stem Cells Transplantation (Auto-SCT) in DLBCL With Poor Prognosis
National Research Center for Hematology, Russia
Phase 3 Unknown
NCT02423837 2015-04-22
BRiF
National Research Center for Hematology, Russia
Phase 3 Unknown
NCT02339350 2015-01-16
Treatment of Newly Diagnosed High Risk Acute Lymphoblastic Leukemia in Children
The Korean Society of Pediatric Hematology Oncology
Phase 2 Unknown
NCT02156726 2014-06-05
Q-lite
Czech CLL Study Group
Unknown
NCT00737685 2012-03-26
Flu+CPM+rATG Conditioning Regimes for Unrelated Bone Marrow Transplantation (UBMT)(or Mobilized Peripheral Blood)in Severe Aplastic Anemia (SAA)
The Korean Society of Pediatric Hematology Oncology
Phase 2 Unknown
NCT00628238 2010-09-10
Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
Chronic Lymphocytic Leukemia Research Consortium
Phase 2 Unknown
NCT00800943 2008-12-03
CRC005
Chronic Lymphocytic Leukemia Research Consortium
Phase 2 Unknown
NCT00774332 2008-10-17
A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL
Cooperative Study Group A for Hematology
Phase 2 Unknown
NCT00561301 2007-11-20
Biweekly Gemcitabine-Oxaliplatin and Dexamethasone for Relapsed/Refractory Malignant Lymphoma
Cooperative Study Group A for Hematology
Phase 2 Unknown